Protalix BioTherapeutics, Inc.

PLX ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
S-8 May 7, 2015 S-8
10-Q May 7, 2015 FORM 10-Q
8-K May 7, 2015 FORM 8-K
SC 13G Apr 21, 2015 SC-13G
SC 13G Apr 20, 2015
10-K Mar 12, 2015 FORM 10-K
8-K Mar 12, 2015 FORM 8-K
SC 13G Feb 17, 2015 CONSONANCE CAPITAL MANAGEMENT LP
SC 13G/A Feb 13, 2015 SC 13G/A
8-K Feb 12, 2015 FORM 8-K
SC 13G/A Feb 11, 2015
8-K Feb 2, 2015 FORM 8-K
SC 13G/A Jan 29, 2015
8-K Jan 8, 2015 FORM 8-K
8-K Jan 5, 2015 FORM 8-K
3 Nov 17, 2014 FORM 3
8-K Nov 12, 2014 FORM 8-K
10-Q Nov 10, 2014 FORM 10-Q
4 Nov 3, 2014 OWNERSHIP DOCUMENT
3 Nov 3, 2014 OWNERSHIP DOCUMENT
DEFA14A Oct 29, 2014 DEFA14A
ARS Oct 22, 2014 AUTO-GENERATED PAPER DOCUMENT
DEF 14A Oct 9, 2014 DEF 14A
4 Oct 6, 2014 OWNERSHIP DOCUMENT
PRE 14A Sep 29, 2014 FORM PRE 14A
← Newer Page 20 of 38 · 935 filings Older →